What is the emergency management of acute ICH in hemophilia A?

Hi,

Welcome to icliniq.com.

I read your query and can understand your concern.

This is a life-threatening situation involving a patient with severe hemophilia A (factor VIII deficiency with levels <1 percent) who has developed an acute intracranial hemorrhage (ICH) along with an expanding subdural hematoma (SDH) (brain bleed under dura). Immediate intervention is required to stabilize hemostasis (blood clotting and control) and manage the worsening neurological condition.

The key challenges and management considerations are as follows:

Severe hemophilia A with critically low factor VIII levels:

The patient’s baseline factor VIII levels (<1 percent) place them at extremely high risk for spontaneous and uncontrolled bleeding.

Despite receiving 30,000 units of factor VIII over eight hours, current levels remain only 30 percent, which is insufficient for effective hemostasis.

Target: Factor VIII levels need to be raised to 100 percent (near-normal levels) to control the hemorrhage and prevent further deterioration.

Acute intracranial hemorrhage (ICH) and expanding subdural hematoma (SDH):

ICH (bleeding within the brain tissue) and SDH (bleeding between the brain's dura mater and arachnoid mater layers) are both medical emergencies due to the risk of increased intracranial pressure (ICP), brain herniation (displacement of brain tissue due to increased intracranial pressure), and neurological deterioration.

Worsening neurological symptoms (such as declining Glasgow Coma scale [GCS] score, unequal pupil size, loss of consciousness) indicate a need for urgent neurosurgical intervention (for example, craniotomy (surgical skull opening procedure) or hematoma evacuation).

Factor VIII supply shortage and alternative hemostatic strategies:

With a critical shortage of factor VIII, alternative therapies must be considered:

1. Desmopressin (DDAVP):

• Desmopressin (DDAVP) is a synthetic analog of vasopressin that stimulates the release of endogenous Factor VIII and von Willebrand factor from endothelial cells.
• DDAVP is only effective in mild to moderate Hemophilia A and is unlikely to provide sufficient factor VIII levels in severe cases.

2. Prothrombin complex concentrates (PCC) or activated PCC (aPCC):

• Prothrombin complex concentrate (PCC) contains clotting factors II, VII, IX, and X, which may provide some hemostatic support.
• Activated PCC (aPCC, for example, FEIBA) is sometimes used in hemophilia patients, particularly if inhibitors are present.
• These are not a direct replacement for Factor VIII and are suboptimal for this scenario.

3. Cryoprecipitate:

• Cryoprecipitate is a plasma-derived product containing Factor VIII, fibrinogen, von Willebrand factor, and Factor XIII.
• It can be used as an emergency substitute when recombinant or plasma-derived Factor VIII concentrates are unavailable.
• Limitation: Less precise and may not provide adequate Factor VIII levels.

Pending inhibitor screen: critical for treatment choice.

Factor VIII inhibitors (alloantibodies) can develop in severe hemophilia A, neutralizing the effectiveness of replacement therapy.

If inhibitors are detected, factor VIII concentrates will not work effectively, and bypassing agents are required instead.

Management if inhibitors are present:

1. Recombinant activated factor VII (coagulation factor VIIa or NovoSeven): Directly promotes clot formation, bypassing the need for factor VIII.

2. Activated PCC is used as an alternative, but with caution due to the risk of thromboembolism (a condition where a blood clot (thrombus) breaks loose and travels through the bloodstream, blocking a vessel).

Neurosurgical request for 100 percent factor VIII levels:

The neurosurgery team requires optimal factor VIII levels to safely proceed with any surgical intervention.

If adequate levels cannot be maintained, the risks of excessive intraoperative bleeding and postoperative hemorrhage increase significantly.

Worsening neurological symptoms, close monitoring required

The signs of increasing intracranial pressure (ICP):

• 1. Decreased level of consciousness.

  2. Unequal or non-reactive pupils.

  3. Hypertension with bradycardia (Cushing’s reflex).

  4. Respiratory irregularities.

Urgent neurosurgical intervention may be required if neurological deterioration continues despite factor supplementation.

Immediate action plan

1. Maximize factor VIII replacement by continuing to administer all available factor VIII concentrate.

2. If supply is critically low, use cryoprecipitate or PCC/aPCC as a temporary measure.

3. Consider alternative hemostatic strategies:

   • If inhibitors are present, switch to recombinant Factor VIIa (NovoSeven) or aPCC (FEIBA) immediately.

   • Desmopressin (DDAVP) can be trialled only if there are no inhibitors, though effectiveness is limited.

Monitor neurological status closely:

1. Frequent Glasgow Coma Scale (GCS) assessments, pupil checks, and vital signs.

2. Immediate repeat CT (computed tomography) brain scan if symptoms worsen.

3. Urgent neurosurgical consultation:

   • If the hematoma (localized collection of blood outside blood vessels) continues expanding or neurological status worsens, emergency craniotomy or hematoma evacuation may be required.

   • Ensure the neurosurgical team is fully informed about Factor VIII status and hemostatic challenges before proceeding.

   • Plan for intensive care management:

4. ICU admission for close monitoring of intracranial pressure (ICP) and coagulation parameters.

5. Maintain strict blood pressure control to prevent further bleeding (avoid excessive hypotension (low blood pressure) or hypertension (high blood pressure).

6. Address transfer limitations due to weather:

If transfer is not possible, optimize all available hospital resources:

1. Teleconsultation with hematology and neurosurgery specialists if needed.

2. Ensure continuous access to factor VIII or alternative treatments.

3. Prepare for on-site surgical intervention if neurological deterioration occurs.

I hope this helps.

Kindly revert so I can assist you further.

Thank you.